Cargando…
Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
BACKGROUND: Adjuvant endocrine treatment improves survival after estrogen receptor (ER) positive breast cancer. Recurrences occur, and most patients with metastatic breast cancer develop treatment resistance and incurable disease. An influential factor in relation to endocrine treatment resistance i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903737/ https://www.ncbi.nlm.nih.gov/pubmed/31821370 http://dx.doi.org/10.1371/journal.pone.0226150 |